CI-719 in hyperlipoproteinaemia: interim data.

Suppr

超能文献

作者信息

Bremner W F, Third J L, Clark B, Corstorphine C, Lawrie T D

出版信息

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):83-7. doi: 10.1177/00359157760690S221.

DOI:10.1177/00359157760690S221

PMID:798201

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1864018/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62c7/1864018/17212b4f3113/procrsmed00035-0090-a.jpg

相似文献

CI-719 in hyperlipoproteinaemia: interim data.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):83-7. doi: 10.1177/00359157760690S221.

The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):78-9. doi: 10.1177/00359157760690S219.

A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.吉非贝齐治疗高脂血症的长期试验。

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):49-52. doi: 10.1177/00359157760690S213.

Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.吉非贝齐和氯贝丁酯治疗高脂血症的比较试验。

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):44-6. doi: 10.1177/00359157760690S211.

Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.吉非贝齐递增剂量治疗高脂蛋白血症的评估。

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):71-5. doi: 10.1177/00359157760690S217.

Gemfibrozil treatment: a comparison with clofibrate.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):88-9. doi: 10.1177/00359157760690S222.

Extrinsic factors affecting the response to gemfibrozil.影响对吉非贝齐反应的外在因素。

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):53-7. doi: 10.1177/00359157760690S214.

Summary of present data from a clinical trial of CI-719.CI-719临床试验的当前数据总结。

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):90-3. doi: 10.1177/00359157760690S223.

A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.吉非贝齐治疗高脂血症的氯贝丁酯对照试验。

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):38-40. doi: 10.1177/00359157760690S209.

Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.吉非贝齐作为高脂血症的降脂化合物。一项安慰剂对照交叉试验。

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):32-7. doi: 10.1177/00359157760690S208.

引用本文的文献

Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.吉非贝齐。对其药效学和药代动力学特性以及在血脂异常治疗中的应用综述。

Drugs. 1988 Sep;36(3):314-39. doi: 10.2165/00003495-198836030-00004.

本文引用的文献

A relation between non-esterified fatty acids in plasma and the metabolism of glucose.血浆中非酯化脂肪酸与葡萄糖代谢之间的关系。

J Clin Invest. 1956 Feb;35(2):150-4. doi: 10.1172/JCI103259.

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.脂蛋白中的脂肪运输——机制与疾病的综合研究方法

N Engl J Med. 1967 Jan 5;276(1):34-42 contd. doi: 10.1056/NEJM196701052760107.

Plasma lipoprotein lipase activity in primary type IV hyperlipoproteinaemia.

Scott Med J. 1972 Jun;17(6):214-6. doi: 10.1177/003693307201700604.

The kinetics of plasma free fatty acid and triglyceride transport in patients with idiopathic hypertriglyceridaemia and their relation to carbohydrate metabolism.

Eur J Clin Invest. 1974 Jun;4(3):149-61. doi: 10.1111/j.1365-2362.1974.tb00386.x.

Plasma free fatty acid and triglyceride transport kinetics in man.人体血浆游离脂肪酸和甘油三酯的转运动力学

Clin Sci Mol Med. 1974 Sep;47(3):259-78. doi: 10.1042/cs0470259.

Familial and acquired type V hyperlipoproteinemia.

Atherosclerosis. 1976 Jan-Feb;23(1):41-62. doi: 10.1016/0021-9150(76)90117-9.

A mechanism by which high-density lipoproteins may slow the atherogenic process.

Lancet. 1976 Jun 19;1(7973):1315-7. doi: 10.1016/s0140-6736(76)92650-7.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验